(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with methylphenidate in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 2 (13.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Ding, YS; Fowler, JS; Gatley, SJ; Sugano, Y; Volkow, ND | 1 |
Alexoff, DA; Chen, R; Dewey, SL; Ding, YS; Fowler, JS; Gatley, SJ; Pan, D | 1 |
Cody, V; Froimowitz, M; Patrick, KS | 1 |
Deutsch, HM; Gruszecka-Kowalik, E; Schweri, MM; Shi, Q | 1 |
Ding, YS; Fowler, JS; Gatley, SJ; Volkow, ND; Wang, GJ | 1 |
Ding, YS; Fowler, JS; Gatley, SJ; King, P; Logan, J; Pappas, N; Volkow, ND; Wang, GJ | 1 |
Deutsch, H; Schenk, JO; Schweri, MM; Wayment, HK | 1 |
Fleckenstein, AE; Hanson, GR; Riddle, EL; Sandoval, V; Ugarte, YV | 1 |
Deutsch, HM; Liu, Z; Schweri, MM; Shi, Q; Ye, X | 1 |
Chen, JC; Hwang, JJ; Liao, MH; Lin, KJ; Pan, WH; Ting, G; Wey, SP; Yen, TC | 1 |
Fleckenstein, AE; Hanson, GR; Rau, KS; Riddle, EL; Topham, MK | 1 |
Bondi, CD; Kozikowski, AP; Kulkarni, SS; Newman, AH; Pan, S; Surratt, CK; Ukairo, OT | 1 |
Deutsch, HM; Kim, DI; Schweri, MM; Ye, X | 1 |
Bardo, MT; Booze, RM; Dwoskin, LP; Gomez, AM; Mactutus, CF; Midde, NM; Wooters, TE; Zhu, J | 1 |
Ananth, M; Hadjiargyrou, M; Komatsu, DE; Robison, LS; Thanos, PK | 1 |
15 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and methylphenidate
Article | Year |
---|---|
Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.
Topics: Animals; Binding, Competitive; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Presynaptic Terminals; Rats; Time Factors | 1995 |
Binding of bromine-substituted analogs of methylphenidate to monoamine transporters.
Topics: Animals; Binding, Competitive; Bromine; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Microdialysis; Motor Activity; Nerve Tissue Proteins; Norepinephrine; Paroxetine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Tomography, Emission-Computed, Single-Photon | 1994 |
Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT.
Topics: Cocaine; Crystallography, X-Ray; Dopamine Uptake Inhibitors; Methylphenidate; Molecular Structure; Stereoisomerism | 1995 |
Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs.
Topics: Animals; Cocaine; Dopamine; Male; Methylphenidate; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1996 |
Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Parkinson Disease; Primates; Radioligand Assay; Radiopharmaceuticals; Reference Values; Substance-Related Disorders; Tomography, Emission-Computed | 1998 |
Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.
Topics: Animals; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Iodine Radioisotopes; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Papio; Radioligand Assay; Tomography, Emission-Computed | 1998 |
Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?
Topics: Algorithms; Amphetamine; Animals; Binding, Competitive; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electrodes; In Vitro Techniques; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Neostriatum; Nerve Tissue Proteins; Phenethylamines; Rats; Rats, Sprague-Dawley | 1999 |
Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biological Transport; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Methamphetamine; Methylphenidate; Models, Biological; Nerve Tissue Proteins; Norepinephrine; Onium Compounds; Organophosphorus Compounds; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes | 2001 |
Synthesis and pharmacology of site specific cocaine abuse treatment agents: a new synthetic methodology for methylphenidate analogs based on the Blaise reaction.
Topics: Animals; Biochemistry; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Methylphenidate; Molecular Structure; Rats; Structure-Activity Relationship | 2001 |
Biodistribution study of [99mTc] TRODAT-1 alone or combined with other dopaminergic drugs in mice with macroautoradiography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Cocaine; Dopamine Agents; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred ICR; Organotechnetium Compounds; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tropanes | 2002 |
Ceramide-induced alterations in dopamine transporter function.
Topics: Animals; Binding, Competitive; Ceramides; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes; Tritium | 2003 |
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Benztropine; Binding, Competitive; CHO Cells; Cocaine; Cricetinae; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Immunohistochemistry; Kinetics; Ligands; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Microscopy, Confocal; Models, Molecular; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Transfection | 2005 |
Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Citalopram; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Male; Methylphenidate; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2007 |
Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Environment; Male; Methylphenidate; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2011 |
Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.
Topics: Administration, Oral; Animals; Autoradiography; Benzazepines; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Methylphenidate; Radiopharmaceuticals; Rats, Inbred SHR; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Tritium | 2017 |